Literature DB >> 10722447

High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

I A Binswanger1, A H Kral, R N Bluthenthal, D J Rybold, B R Edlin.   

Abstract

The prevalence of and risk factors for abscesses and cellulitis were investigated among a community sample of injection drug users (IDUs). Participants were interviewed, and those with symptoms were examined. Of 169 IDUs, 54 (32%) had abscesses (n=35), cellulitis (n=5), or both (n=14); 27% had lanced their own abscesses; and 16% had self-treated with antibiotics they purchased on the street. IDUs who skin-popped (injected subcutaneously or intramuscularly) were more likely to have an abscess or cellulitis than those who had injected only intravenously (odds ratio, 4.9; 95% confidence interval, 2.2-11). The likelihood of abscesses and cellulitis increased with frequency of skin-popping and decreased with increasing duration of injection drug use. Abscesses are extremely prevalent among IDUs in San Francisco. Skin-popping is a major risk factor, and self-treatment is common.

Entities:  

Mesh:

Year:  2000        PMID: 10722447     DOI: 10.1086/313703

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  97 in total

1.  Skin and Soft Tissue Infections in Injection Drug Users.

Authors:  Patricia D. Brown; John R. Ebright
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

2.  Recent incarceration linked to cutaneous injection-related infections among active injection drug users in a Canadian setting.

Authors:  M-J Milloy; Evan Wood; Elisa Lloyd-Smith; Eric Grafstein; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Community Health       Date:  2010-12

3.  Risk practices associated with bacterial infections among injection drug users in Denver, Colorado.

Authors:  Kristina T Phillips; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2010-03       Impact factor: 3.829

4.  Hospital utilization for injection drug use-related soft tissue infections in urban versus rural counties in California.

Authors:  Keith G Heinzerling; David A Etzioni; Brian Hurley; Paul Holtom; Ricky N Bluthenthal; Steven M Asch
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

5.  Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.

Authors:  Ricky N Bluthenthal; D Phuong Do; Brian Finch; Alexis Martinez; Brian R Edlin; Alex H Kral
Journal:  J Urban Health       Date:  2007-07-27       Impact factor: 3.671

6.  US hospitalizations and costs for illicit drug users with soft tissue infections.

Authors:  Traci A Takahashi; Matthew L Maciejewski; Katharine Bradley
Journal:  J Behav Health Serv Res       Date:  2009-04-21       Impact factor: 1.505

7.  Directly observed therapy with azithromycin for skin and soft tissue infections in injection drug users.

Authors:  Harout K Tossonian; Brian Conway; Jesse D Raffa; Mark Viljoen; Milan Khara; Annabel Mead; Heather Culbert; Stanley Devlaming
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

8.  US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015.

Authors:  Cora Peterson; Likang Xu; Christina A Mikosz; Curtis Florence; Karin A Mack
Journal:  J Subst Abuse Treat       Date:  2018-06-20

9.  Lethal endomyocarditis caused by chronic "Krokodil" intoxication.

Authors:  Antonella Sorrentino; Silvia Trotta; Anna Pia Colucci; Lucia Aventaggiato; Andrea Marzullo; Biagio Solarino
Journal:  Forensic Sci Med Pathol       Date:  2018-03-19       Impact factor: 2.007

10.  Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities.

Authors:  David S Fink; Suzanne P Lindsay; Donald J Slymen; Alex H Kral; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2013-04-12       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.